Process View
Any process that stops, prevents, or reduces the frequency, rate or extent of leukocyte proliferation.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of leukocyte proliferation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| HLA-B | major histocompatibility complex, class I, B | 0.677 | ||
| B2M | beta-2-microglobulin | 0.638 | ||
| HLA-C | major histocompatibility complex, class I, C | 0.553 | Human | |
| CD80 | CD80 molecule | 0.525 | ||
| HLA-G | major histocompatibility complex, class I, G | 0.439 | ||
| HLA-A | major histocompatibility complex, class I, A | 0.427 | Human | |
| HLA-F | major histocompatibility complex, class I, F | 0.348 | Human | |
| LILRA6 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 | 0.301 | ||
| LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | 0.271 | ||
| CD86 | CD86 molecule | 0.184 | ||
| PILRA | paired immunoglobin-like type 2 receptor alpha | 0.178 | ||
| HLA-E | major histocompatibility complex, class I, E | 0.176 | Human | |
| TRAF1 | TNF receptor-associated factor 1 | 0.157 | ||
| FSTL1 | follistatin-like 1 | 0.139 | ||
| INPP5D | inositol polyphosphate-5-phosphatase, 145kDa | 0.128 | Mouse | |
| CCL4 | chemokine (C-C motif) ligand 4 | 0.092 | Human | |
| HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.072 | ||
| TFF1 | trefoil factor 1 | 0.071 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.070 | ||
| HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.053 | Human | |
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.053 | ||
| POU3F2 | POU class 3 homeobox 2 | 0.052 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.049 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.048 | Mouse | |
| CCR5 | chemokine (C-C motif) receptor 5 | 0.047 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.045 | ||
| IL22RA1 | interleukin 22 receptor, alpha 1 | 0.044 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.041 | ||
| IDE | insulin-degrading enzyme | 0.041 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.041 | ||
| HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.040 | ||
| APP | amyloid beta (A4) precursor protein | 0.040 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.038 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.038 | ||
| SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.034 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.033 | Human | |
| CD33 | CD33 molecule | 0.030 | ||
| IL10RA | interleukin 10 receptor, alpha | 0.030 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.029 | Human | |
| CCL8 | chemokine (C-C motif) ligand 8 | 0.029 | Human | |
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.029 | ||
| BTN3A2 | butyrophilin, subfamily 3, member A2 | 0.029 | ||
| IL10 | interleukin 10 | 0.028 | ||
| ADAM17 | ADAM metallopeptidase domain 17 | 0.027 | ||
| HK3 | hexokinase 3 (white cell) | 0.027 | ||
| LILRA1 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 | 0.026 | Human | |
| GRAP2 | GRB2-related adaptor protein 2 | 0.026 | ||
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.025 | ||
| SYK | spleen tyrosine kinase | 0.023 | ||
| FPR3 | formyl peptide receptor 3 | 0.023 | ||
| FCGR2C | Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene) | 0.023 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.023 | ||
| IFNG | interferon, gamma | 0.022 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.022 | ||
| MARCO | macrophage receptor with collagenous structure | 0.022 | ||
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.022 | ||
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.022 | ||
| IL1B | interleukin 1, beta | 0.021 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.020 | Human | |
| TRAF5 | TNF receptor-associated factor 5 | 0.020 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.019 | Human | |
| CCL7 | chemokine (C-C motif) ligand 7 | 0.017 | Human | |
| CCR7 | chemokine (C-C motif) receptor 7 | 0.017 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.017 | ||
| AIF1 | allograft inflammatory factor 1 | 0.017 | ||
| TNFSF14 | tumor necrosis factor (ligand) superfamily, member 14 | 0.016 | ||
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.015 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.015 | ||
| EPOR | erythropoietin receptor | 0.015 | ||
| NLRP3 | NLR family, pyrin domain containing 3 | 0.015 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.014 | ||
| IL22RA2 | interleukin 22 receptor, alpha 2 | 0.014 | ||
| LILRA2 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 | 0.014 | ||
| CCR4 | chemokine (C-C motif) receptor 4 | 0.014 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.014 | ||
| CMKLR1 | chemokine-like receptor 1 | 0.013 | ||
| CD163 | CD163 molecule | 0.013 | ||
| FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.013 | ||
| IL8 | interleukin 8 | 0.013 | ||
| ENG | endoglin | 0.013 | ||
| CYTH4 | cytohesin 4 | 0.012 | ||
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.012 | ||
| SIGLEC7 | sialic acid binding Ig-like lectin 7 | 0.012 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.012 | ||
| PAX3 | paired box 3 | 0.012 | ||
| HCK | hemopoietic cell kinase | 0.012 | ||
| TAP1 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | 0.012 | ||
| RNF111 | ring finger protein 111 | 0.012 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.012 | ||
| IL2RA | interleukin 2 receptor, alpha | 0.012 | Mouse | |
| TNF | tumor necrosis factor | 0.012 | ||
| PLK3 | polo-like kinase 3 | 0.012 | ||
| CCDC85B | coiled-coil domain containing 85B | 0.011 | ||
| CLEC10A | C-type lectin domain family 10, member A | 0.011 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.011 | ||
| IDO1 | indoleamine 2,3-dioxygenase 1 | 0.011 | ||
| SLAMF7 | SLAM family member 7 | 0.011 | ||
| SMAD7 | SMAD family member 7 | 0.011 | ||
| FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | 0.011 | Mouse | |
| SLAMF8 | SLAM family member 8 | 0.011 | ||
| C3 | complement component 3 | 0.011 | ||
| CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.011 | ||
| C1QB | complement component 1, q subcomponent, B chain | 0.011 | ||
| CH25H | cholesterol 25-hydroxylase | 0.011 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.011 | ||
| IKZF3 | IKAROS family zinc finger 3 (Aiolos) | 0.011 | ||
| IFITM2 | interferon induced transmembrane protein 2 (1-8D) | 0.011 | ||
| HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.011 | ||
| IL2RB | interleukin 2 receptor, beta | 0.011 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.011 | ||
| CD14 | CD14 molecule | 0.011 | ||
| NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 0.010 | ||
| LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.010 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.010 | ||
| CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.010 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.010 |